Upon completion of this educational activity, participants should be able to:
discuss current scientific data regarding the diagnosis and treatment of neurological disease;
discuss the pathogenesis and treatment of pain;
describe the basic science of brain function;
discuss new information regarding new drugs for commonly diagnosed neurological conditions and new uses for traditional drugs;
identify nonclinical issues of importance for the neurologist.
Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Relias LLC designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Neurology Alert’s Editor in Chief Matthew Fink, MD; Peer Reviewer M. Flint Beal, MD; Editorial Group Manager Leslie Coplin; Editor Jason Schneider; and Accreditations Manager Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.
You are not currently logged in.
To view content articles and access course testing and evaluation, please login or register now